George Ambartsoumian, CEO and PresidentThis challenge is the driving force behind GA International. As a pioneering leader in advanced identification technologies, the company has made sample integrity its mission. Through its life sciences brand, LabTAG, it delivers end-to-end identification solutions tailored to biomedical research, manufacturing, and clinical workflows. By integrating hardware, software, and technical expertise, LabTAG provides a dependable framework for data accuracy and compliance. From bench to bedside, it protects the process, ensuring discoveries advance and patient safety is never compromised.
“Our goal is to help the scientific community have more efficient sample management solutions,” says George Ambartsoumian, CEO and president.
To further reduce manual errors and save valuable time, LabTAG also provides pre-labeled labware, including tubes, vials, plates, and more. These ready-to-use solutions safeguard data integrity from the moment a sample is collected, helping laboratories work smarter and faster.
Complementing the labels are hardware solutions, including printers, barcode and RFID scanners, that integrate seamlessly into existing workflows. Labels with unique barcodes or RFID tags can be scanned at every stage, enabling real-time sample tracking, automatic record keeping, and a significant reduction in manual errors.
Tying it all together is labeling software, compatible with most printing formats and LIMS systems. By automatically capturing and recording data, such software minimizes transcription errors, strengthens compliance, and accelerates lab processes.
-
Our goal is to help the scientific community have more efficient sample management solutions.
Its team of expert scientists provides free consulting and technical assistance, guiding clients from solution development through ongoing troubleshooting. The holistic approach ensures that labs are not just buying labels or equipment, but gaining a complete identification solution built to protect sample integrity and enable scientific progress.
The impact of LabTAG’s solutions is evident at The Neuro’s C-BIGR Open Biobank, where mislabeled frozen samples once slowed neurological research. After testing LabTAG’s Blackout CryoSTUCK® labels, which adhere directly to frozen vials at -80°C and integrate with the LORIS LIMS, the biobank cut processing times in half and helped in accelerating workflows in the fight against neurological disorders.
Its dedicated R&D teams drive such results. They continuously develop new products and labeling technologies, ensuring clients have access to the best solutions. Investments in eco-friendly inks and substrates testify to its environmental responsibility.
LabTAG by GA International’s innovative spirit is reflected in its collaboration with Dymo®, a Newell Brands subsidiary, to develop direct thermal cryogenic labels for Dymo® LabelWriter™ 550 Series printers. These labels adhere securely to frozen vials, withstand liquid nitrogen at -196°C, and offer a compact, cost-effective alternative to larger printers.
To ensure compatibility with its Protected Design and patent-pending SnapPEEL™ technology, the team also developed custom label templates precisely aligned with the printer requirements.
GA International plans to expand its facilities, acquire advanced manufacturing and testing equipment, commercialize new inventions, and move towards GMP compliance. Branching out from the life sciences, its technologies are applied in specialized industries such as the electrical and automotive sectors and beyond.
Marking 26 years in business, with more than 25 granted patents and over 30 pending, GA International continues to strengthen its position as an innovator.
Biopharma Label Identification Solution Info
What has positioned GA International among Top Biopharma Label Identification Solutions providers?
Advanced labeling technologies and a strong focus on sample integrity have helped GA International gain recognition among Top Biopharma Label Identification Solutions providers. Through its LabTAG brand, the company develops specialized labeling systems designed for biomedical research, clinical laboratories and biopharmaceutical workflows. Its solutions are engineered to maintain identification accuracy under demanding conditions such as cryogenic storage, chemical exposure and autoclave sterilization. This combination of durability, traceability and laboratory-focused innovation has strengthened GA International’s position within biopharma label identification solutions.
How does GA International differentiate its labeling technology approach?
GA International emphasizes integrated sample identification systems rather than standalone labeling products. The company structures its biopharma label identification solutions around specialized labels, barcode and RFID technologies, compatible software and workflow integration support. Its portfolio includes cryogenic labels, chemical-resistant labels and thermal-transfer solutions designed to support accurate tracking across laboratory environments. By combining hardware, software and technical expertise, GA International helps laboratories reduce identification errors and strengthen workflow reliability.
How does the company support laboratory efficiency and sample traceability?
Reliable sample tracking is essential for research accuracy, regulatory compliance and clinical workflow continuity. GA International supports biopharma label identification solutions through labeling systems that enable real-time sample tracking, automated record keeping and integration with LIMS platforms. Its pre-labeled labware and durable barcode technologies help laboratories reduce manual processing time while improving traceability across research and storage environments. This focus on workflow optimization contributes to stronger data integrity and more efficient laboratory operations.
What role does innovation play in GA International’s solutions?
Continuous research and product development remain central to the company’s growth strategy. GA International applies advanced materials science and laboratory identification expertise to strengthen biopharma label identification solutions across evolving research applications. Its development of direct thermal cryogenic labels and specialized technologies such as SnapPEEL™ reflects the company’s focus on solving practical laboratory challenges. Investments in eco-friendly materials, new manufacturing capabilities and compatibility with advanced laboratory systems also reinforce its innovation-driven approach.
How do biopharma label identification solutions create value through GA International?
Laboratory value depends heavily on reliable sample management, accurate identification and workflow efficiency. GA International delivers biopharma label identification solutions that help organizations improve sample traceability, reduce processing errors and maintain compliance across laboratory operations. Its integrated technologies also support faster sample handling and more dependable data management in research and clinical environments. This balance between technical durability and workflow integration increases the long-term value of the company’s identification solutions.
Why is GA International relevant to the future of laboratory identification systems?
Life sciences organizations continue to prioritize automation, traceability and data integrity as laboratory workflows become increasingly complex. GA International contributes to this evolution through biopharma label identification solutions focused on durable labeling technologies, workflow integration and advanced sample tracking capabilities. Its emphasis on innovation and laboratory compatibility aligns with industry priorities surrounding research accuracy, compliance and digital laboratory management. As laboratories adopt more data-driven systems, the company remains relevant to the future of scientific identification technologies.
